Asia PDL1 Study Among NSCLC Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hiroyuki Suzuki, Dr.
Fukushima Medical University Hospital
Principal Investigator - Li Zhang, Prof.
Sun Yat-Sen University Cancer Center
Principal Investigator - Noriyuki Ebi, Dr.
Aso Co.,Ltd Iizuka Hospital
Principal Investigator - Ping Yu, Prof.
Sichuan Province Cancer Hospital
Principal Investigator - Sang-We Kim, Prof.
Asan Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Guangzhou, Guangdong, China
- Research Site
Iizuka-shi, Fukuoka, Japan
- Research Site
Fukushima, Fukushima, Japan
- Research Site
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Oct 2015
- Primary completion
- 27 Feb 2017
- Completion
- 27 Feb 2017
- Last update posted
- 28 Feb 2018
- Registered enrollment
- 658
- Registry id
- NCT03037086
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.